scholarly journals Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma

1992 ◽  
Vol 65 (5) ◽  
pp. 731-734 ◽  
Author(s):  
PA Pasanen ◽  
M Eskelinen ◽  
K Partanen ◽  
P Pikkarainen ◽  
I Penttilä ◽  
...  
Keyword(s):  
Pancreatic Carcinoma ◽  
Clinical Evaluation ◽  
Tumour Marker ◽  
Ca 242 ◽  
Serum Tumour Marker ◽  
Serum Tumour

scholarly journals Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer

1993 ◽  
Vol 67 (6) ◽  
pp. 1423-1429 ◽  
Author(s):  
JL Pujol ◽  
EH Cooper ◽  
M Lehmann ◽  
DA Purves ◽  
M Dan-Aouta ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Clinical Evaluation ◽  
Cell Lung Cancer ◽  
Tumour Marker ◽  
Small Cell ◽  
Small Cell Lung ◽  
Ca 242 ◽  
Serum Tumour Marker ◽  
Serum Tumour

Correlation between tumor markers in pre and post treatment of pancreatic cancer patients

2021 ◽  
Vol 25 (1) ◽  
pp. 70-74
Author(s):  
N. Sivakumar ◽  
R. Arivazhagan ◽  
B. Prabasheela
Keyword(s):  
Pancreatic Cancer ◽  
Tumour Marker ◽  
Serum Marker ◽  
Carbohydrate Antigen ◽  
Tumour Markers ◽  
Post Treatment ◽  
Treatment Groups ◽  
Serum Tumour Marker ◽  
Before And After ◽  
Serum Tumour

One of the main causes of death in India is pancreas cancer. Various blood tumour indicators such as 19-9 carbohydrate antigen (CA19-9), antigen125 carbohydrate (CA125), antigen carcinoembryogenic (CEA) and alphaetoprotein (AFP) imbalance are observed in therapy for cancer. In disease predictions, thorough monitoring of the change in serum tumour markers was highly essential. The present investigation was thus conducted to examine serum marker tumour profiles before and after therapy of individuals with pancreatic cancer. The study comprised 400 individuals from both sexes suffering from pancreatic carcinogenic malignancy. In the pre and post-treatment of patients we detected serum tumour markers. In post-treatment groups, serum tumour marker levels were lower than before the individuals were treated. However, using pairs of samples t-testing at pfleg.0.05 these changes were statistically significant. Marker alterations in the serum tumour have shown risk for individuals. These alterations therefore enable the cancer individuals to predict and monitor properly.

scholarly journals Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer

1986 ◽  
Vol 53 (2) ◽  
pp. 197-202 ◽  
Author(s):  
C Haglund ◽  
P J Roberts ◽  
P Kuusela ◽  
T M Scheinin ◽  
O Mäkelä ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Tumour Marker ◽  
Serum Tumour Marker ◽  
Serum Tumour
Sign in / Sign up

Export Citation Format

Share Document